Entresto’s longest-lasting active component takes roughly two to three days to fully clear your body. The drug contains two active ingredients that break down at different rates, so there isn’t one single number. The slowest component has a half-life of about 11.5 hours, meaning it takes approximately 57 hours (just under 2.5 days) to drop to negligible levels.
How Entresto Breaks Down in Your Body
Entresto is a combination of two drugs: sacubitril and valsartan. Once you swallow a tablet, sacubitril is rapidly converted by enzymes into its active form, called LBQ657. So in practice, three substances matter when thinking about how long the drug stays in your system.
Each one clears at a different speed:
- Sacubitril has a half-life of about 1.4 hours. It converts to its active form so quickly that it’s essentially gone within 7 hours.
- LBQ657 (the active form of sacubitril) has a half-life of about 11.5 hours. This is the slowest component to leave your body, taking roughly 57 hours, or about 2.5 days, to be fully eliminated.
- Valsartan has a half-life of about 9.9 hours. It clears in about 50 hours, or just over two days.
These estimates use the standard pharmacology rule that a drug is considered cleared after about five half-lives, the point at which less than 3% of the last dose remains in your bloodstream.
Why LBQ657 Sets the Timeline
Even though sacubitril itself vanishes within hours, its active metabolite LBQ657 is the component doing the therapeutic work and lingering the longest. When you take Entresto twice daily, LBQ657 accumulates to about 1.6 times the level of a single dose. Sacubitril and valsartan, by contrast, don’t build up significantly with regular dosing. Steady-state levels of all three substances are reached within about three days of starting the medication.
This means that if you stop taking Entresto, the clock starts from that slightly elevated LBQ657 level. For most people, it will still be functionally cleared within about 2.5 days of the last dose.
How Your Body Eliminates Entresto
The two components leave through different routes. LBQ657 is primarily cleared through the kidneys, with roughly 52 to 68% of the sacubitril-derived material exiting in urine. Valsartan takes the opposite path: about 86% is eliminated through bile and feces, with only around 9% leaving through urine. Valsartan is also minimally broken down by the liver, with about 80% excreted in its original form.
Kidney and Liver Problems Slow Clearance
If your kidneys or liver aren’t functioning well, Entresto takes longer to leave your system. Since LBQ657 depends heavily on kidney filtration, reduced kidney function means the drug hangs around at higher concentrations. People with severe kidney impairment (an eGFR below 30) are typically started at half the usual dose for this reason.
Liver function matters too, primarily for the valsartan component. People with moderate liver impairment also start at half the normal dose. Entresto is not recommended at all for people with severe liver disease, because the drug hasn’t been studied in that population and clearance could be unpredictably slow.
For someone with healthy kidneys and liver, the 2.5-day clearance estimate is reliable. With significant organ impairment, it could stretch longer, though exact timelines vary by individual.
The 36-Hour Washout Rule
The most common reason people ask about Entresto’s clearance time is switching medications. If you’re transitioning between Entresto and an ACE inhibitor (like lisinopril or enalapril), a mandatory 36-hour gap is required between the two drugs, regardless of which direction you’re switching. Taking both within that window significantly raises the risk of angioedema, a potentially dangerous swelling of the face, lips, tongue, or throat.
This 36-hour window is built around the clearance rates of the active components. By 36 hours, enough of the drug has left your system to make the overlap with an ACE inhibitor far less dangerous. It’s one of the few hard timing rules in cardiology prescribing, and it applies every time, not just the first switch.
Switching to or from an ARB (a different class of blood pressure drug) does not require this washout period, since the angioedema risk is specific to the interaction between sacubitril’s mechanism and ACE inhibitors.
What This Means After Stopping Entresto
If you’ve stopped taking Entresto entirely, the drug’s blood pressure-lowering and heart-protective effects will fade over the same two-to-three-day window as the drug clears. You won’t feel a sudden change at the moment you skip a dose, because the twice-daily dosing schedule means drug levels are already fluctuating throughout the day. But by 48 to 60 hours after your last tablet, the active components will be at trace levels and no longer producing meaningful effects.
For people who miss a single dose, the levels don’t drop to zero because the next scheduled dose replenishes them. The concern about full clearance is most relevant when stopping the medication altogether or switching to another drug that could interact with it.